GPCR
Structure Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$47.34
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-15.9%
Return on equity
-15.1%
Return on assets
-19.0%
Return on invested capital
0.00x
Asset turnover
-$220.2M
Cash from operations
$19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026